Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
AMYLOID FLORBETABEN INJECTIONSDepartment of Veterans Affairs$437.5K obligationsEnds Sep 30, 2024
PYLARIFY ORDERING PERIOD 3Department of Veterans Affairs$2.1M obligationsEnds Dec 31, 2025
RADIO-PHARMACEUTICAL FOR PATIENT CARE.Department of Defense$21.9K obligationsEnds Sep 30, 2026
RADIOACTIVE ISOTOPES PET TRACER IDC ORDERING YEAR THREE FOR MEDVAMCDepartment of Veterans Affairs$339.6K obligationsEnds Feb 28, 2027
OPTION YEAR 1Department of Veterans Affairs$155.2K obligationsEnds Aug 31, 2024
PET MRI RADIOPHARMACEUTICALSDepartment of Veterans Affairs$610.7K obligationsEnds Sep 30, 2025
PET-CT DOSE KC VAMCDepartment of Veterans Affairs$252.8K obligationsEnds Jan 8, 2027
BPA CALL ORDER FOR RADIOACTIVE PHARMACEUTICALS REQUIRED FOR POSITRON EMISSION TOMOGRAPHY (PET).Department of Defense$249.8K obligationsEnds Jan 14, 2027
RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT.Department of Defense$10.8K obligationsEnds Sep 30, 2026
RADIOPHARMACEUTICALS REQUIREMENT IS NECESSARY TO SUPPORT THE DEPARTMENT OF RADIOLOGY, NUCLEAR MEDICINE CLINIC.Department of Defense$187.9K obligationsEnds Sep 30, 2026
PYLARIFYDepartment of Veterans Affairs$241.8K obligationsEnds Dec 15, 2025
PYLARIFY F-18 DCFPYLDepartment of Veterans Affairs$992.4K obligationsEnds May 31, 2025
RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENTDepartment of Defense$25.3K obligationsEnds Sep 30, 2026
DELIVERY ORDER FOR PRICING YEAR ONE ON IDC 36C25624D0046 FOR RADIOACTIVE PET TRACER ISOTOPES FOR MEDVAMCDepartment of Veterans Affairs$235.8K obligationsEnds Feb 28, 2025
PHARMACEUTICALS NEEDED FOR PATIENT CARE.Department of Defense$36.1K obligationsEnds Sep 30, 2026
NEURACEQDepartment of Veterans Affairs$279.5K obligationsEnds Oct 2, 2026
F18 PROSTATE-SPECIFIC MEMBRANE AGENT (PSMA) - OPTION YEAR 3Department of Veterans Affairs$216.5K obligationsEnds Aug 31, 2026
RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENTDepartment of Defense$14.4K obligationsEnds Sep 30, 2025
RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENT SOFIE (S0F-NEURACEQ)Department of Defense$43.7K obligationsEnds Sep 30, 2025
PYLARIFY RADIO PHARM.Department of Veterans Affairs$822.8K obligationsEnds Jul 14, 2025
RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENTDepartment of Defense$14.4K obligationsEnds Sep 30, 2025
BASE YEAR NEURACEQDepartment of Veterans Affairs$0 obligationsEnds Dec 31, 2024
RADIOPHARMACEUTICALSDepartment of Veterans Affairs$488.4K obligationsEnds May 31, 2025
THIS IS FOR THE PURCHASE AND DELIVERY OF PYLARIFY.Department of Veterans Affairs$1.1M obligationsEnds Jun 10, 2025
RADIO-PHARMACEUTICALSDepartment of Defense$43.7K obligationsEnds Sep 30, 2025